ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (NASDAQ: RTIX), a leading processor of orthopedic and other biologic implants, announced today that the company’s revenues were $29.9 million for the first quarter of 2008, compared to $22.0 million for the first quarter 2007.
